Brookwood Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Buy
19,737
+10,165
+106% +$266K 0.05% 311
2026
Q1
$269K Sell
9,572
-9,469
-50% -$252K 0.03% 418
2025
Q4
$474K Buy
19,041
+1,449
+8% +$36.5K 0.06% 299
2025
Q3
$448K Sell
17,592
-135
-0.8% -$3.33K 0.06% 285
2025
Q2
$430K Buy
17,727
+8,750
+97% +$204K 0.07% 271
2025
Q1
$227K Buy
+8,977
New +$235K 0.04% 365

Other funds holding PFE

Brookwood Investment Group's PFE Position: Q2 2026 in Review

Brookwood Investment Group increased its Pfizer (PFE) stake by 106% in Q2 2026, buying an estimated $266K and bringing the position to 19,737 shares worth $475K. The position accounts for 0.05% of the portfolio, ranked #311.

Brookwood Investment Group first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Brookwood Investment Group held 19,737 shares of Pfizer worth $475K as of Q2 2026.
  • Brookwood Investment Group bought 10,165 Pfizer shares in Q2 2026, an estimated $266K.
  • Pfizer made up 0.05% of Brookwood Investment Group's portfolio in Q2 2026, its #311 holding.
  • Brookwood Investment Group first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.